Article PDF
References
Woods SC, Porte Jr D (1974) Neural control of the endocrine pancreas. Physiol Rev 54: 596–619
Miller RE (1981) Pancreatic neuroendocrinology: Peripheral neural mechanisms in the regulation of the islets of Langerhans. Endocrin Rev 4: 471–494
Ahrén B (1981) On the peptidergic and aminergic regulation of insulin secretion. PhD Thesis, University of Lund, Sweden
Steffens AB, Strubbe JH (1983) CNS regulation of glucagon secretion. In: Szabo AJ (ed) Advances in Metabolic Disorders, volume 10. Academic, New York London, pp 221–257
Prinz RA, El Sabbagh H, Adrian TE, Bloom SR, Gardner I, Polak JM, Inokuchi H, Bishop AE, Welbourn RB (1983) Neural regulation of pancreatic polypeptide release. Surgery 94:1011–1018
Godfrey DA, Matschinsky FM (1975) Enzymes of the cholinergic system in islets of Langerhans. J Histochem Cytochem 23: 645–651
Ahrén B, Taborsky Jr GJ (1986) The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog. Endocrinology 118:1551–1557
Bloom SR, Edwards AV (1981) Pancreatic endocrine responses to stimulation of the peripheral ends of the vagus nerves in conscious calves. J Physiol 315: 31–41
Holst JJ, Gronholt R, Schaffalitzky de Muckadell OB, Fahrenkrug J (1981) Nervous control of pancreatic endocrine secretion in pigs. 2. The effect of pharmacological blocking agents on the response to vagal stimulation. Acta Physiol Scand 111: 9–14
Holst JJ, Gronholt R, Schaffalitzky de Muckadell OB, Fahrenkrug J (1981) Nervous control of pancreatic endocrine secretion in pigs. V. Influence of the sympathetic nervous system on the pancreatic secretion of insulin and glucagon, and on the insulin and glucagon response to vagal stimulation. Acta Physiol Scand 113: 278–283
Iversen J (1973) Effect of acetylcholine on the secretion of glucagon and insulin from the isolated, perfused canine pancreas. Diabetes 22: 381–387
Kaneto A, Sata H, Kaneko T, Yanaihara C, Yanaihara N, Kosaka K (1981) Stimulation of somatostatin, pancreatic polypeptide, glucagon and insulin secretion by acetylcholine infused intrapancreatically in dogs. Biomed Res 2: 57–66
Ahrén B, Lundquist I (1982) Interaction of vasoactive intestinal peptide (VIP) with cholinergic stimulation of glucagon secretion. Experientia 38: 405–406
Palmer JP, Werner PL, Hollander B, Ensinck JW (1979) Evaluation of the control of glucagon secretion by the parasympathetic nervous system in man. Metabolism 28: 549–552
Holst JJ, Jensen SL, Knuhtsen S, Nielsen OV (1983) Autonomic nervous control of pancreatic somatostatin secretion. Am J Physiol 245: E542-E548
Samols E, Stagner JI (1981) Autonomic function and control of pancreatic somatostatin. Diabetologia 20: 388–392
Hermansen K (1980) Secretion of somatostatin from the normal and diabetic pancreas. Studies in vitro. Diabetologia 19:492–504
Ahrén B, Paquette TL, Taborsky Jr GJ (1986) Effect and mechanism of vagal nerve stimulation on somatostatin secretion in dogs. Am J Physiol 250: E212-E217
Taborsky Jr GJ, Ensinck JW (1984) Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dogs. J Clin Invest 73: 216–223
Schwartz TW, Holst JJ, Fahrenkrug J, Jensen SL, Nielsen OV, Rehfeld JF, Schaffailtzky de Muckadell OB, Stadil F (1978) Vagal cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest 61: 781–789
Stubbe JH (1982) Effects of pancreas transplantation on insulin secretion in rats during ingestion of varying glucose loads. Diabetologia 22: 354–357
Berthoud MR (1984) The relative contribution of the nervous system, hormones, and metabolites to the total insulin response during a meal in the rat. Metabolism 33: 18–25
Pettersson M, Ahrén B, Lundquist 1, Böttcher G, Sundler F (1986) Neuropeptide Y: intrapancreatic neuronal localization and inhibitory effects on glucose-stimulated insulin secretion in the mouse. Cell Tissue Res (in press)
Marliss EB, Girardier L, Seydoux J, Wolheim CD, Kanazawa Y, Orci L, Renold AE, Porte Jr D (1973) Glucagon release induced by pancreatic nerve stimulation in the dog. J Clin Invest 52: 1246–1259
Bloom SR, Edwards AV (1978) Certain pharmacological characteristics of the release of pancreatic glucagon in response to stimulation of the splanchnic nerves. J Physiol 280: 25–35
Iversen LL (1971) Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41: 571–591
Westfall TC (1984) Evidence that noradrenergic transmitter release is regulated by presynaptic receptors. Fed Proc 43: 1352–1357
Ahrén B, Veith RC, Taborsky Jr GJ Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 1) Effects on basal release of insulin and glucagon. Endocrinology (in press)
Roy MW, Lee KC, Jones MS, Miller RE (1984) Neural control of pancreatic insulin and somatostatin secretion. Endocrinology 115: 770–775
Ahrén B, Veith RC, Paquette TL, Taborsky Jr GJ Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2) Effects on basal release of somatostatin and pancreatic polypeptide. Endocrinology (in press)
Bloom SR, Edwards AV (1984) Characteristics of the neuroendocrine responses to stimulation of the splanchnic nerves in bursts in the conscious calf. J Physiol 346: 533–545
Cryer PE, Rizza RA, Haymond MW, Gerich JE (1980) Epinephrine and norepinephrine are cleared through β-adrenergic, but not α-adrenergic, mechanisms in man. Metabolism 29 (Suppl 1): 1114–1118
Taborsky Jr GJ, Halter JB, Baum D, Best JD, Porte Jr D (1984) Pentobarbital anesthesia suppresses basal and 2-deoxy-glucose stimulated plasma catecholamines. Am J Physiol 247: R905–8910
Ahrén B, Lundquist I (1985) Effects of a-adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the mouse. Acta Physiol Scand 125: 211–217
Baum D, Porte Jr D (1980) Stress hyperglycemia and the adrenergic regulation of pancreatic hormones in hypoxia. Metabolism 29 (Suppl 1): 1170–1185
Skoglund G, Lundquist I, Ahrén B (1986) Effects of α1- and α2-adrenoceptor stimulation and blockade on plasma insulin levels in the mouse. Pancreas: 415–420
Kaneto A, Miki E, Kosaka K (1975) Effect of β- and β2-adrenoceptor stimulants infused intrapancreatically on glucagon and insulin secretion. Endocrinology 97: 1166–1173
Furman BL, Tayo FM (1974) Effect of some β-adrenoceptor blocking drugs on insulin secretion in the rat. J Pharm Pharmacol 26:512–517
Samols E, Weir GC (1979) Adrenergic modulation of pancreatic A, B and D cells. α-Adrenergic suppression and β-adrenergic stimulation of somatostatin secretion, α-adrenergic stimulation of glucagon secretion in the perfused dog pancreas. J Clin Invest 63: 230–238
Sive AA, Vinik AI, Levitt N (1980) Adrenergic modulation of human pancreatic polypeptide (hPP) release. Gastroenterology 79: 665–672
Palmer JP, Henry DP, Benson JW, Johnson DG, Ensinck JW (1976) Glucagon response to hypoglycemia in sympathectomized man. J Clin Invest 57: 522–525
Hisatomi A, Maruyama H, Orci L, Vasko M, Unger RH (1985) Adrenergicaliy mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas. J Clin Invest 75:420–426
Helman A, Gilbert M, Pfisler-Lemaire N, Reach G, Assan R (1984) Glucagon and insulin secretion and their biological activities in hypothermic rats. Endocrinology 115: 1722–1728
Brockman RP, Halvorson R (1982) Glucose, glucagon, and insulin during adrenergic blockade in exercising sheep. J Appl Physiol 52:315–319
Dunning BE, Verbalis JG, Fawcett CP (1985) Evidence for participation of the neurohypophysial hormones in the hyperglucagonemic response to hemorrhage in the rat. Neuroendocrinology 41: 385–389
Klaff LJ, Taborsky Jr GJ Pancreatic somatostatin as a mediator of the inhibition of glucagon by hyperglycemia. Diabetes (in press)
Samols E, Bonner-Weir S, Weir GC (1986) Intra-islet insulinglucagon-somatostatin relationships. Clin Endocrinol Metab 14: 33–58
Maruyama H, Hisatomi A, Orci L, Grodsky GM, Orci RH (1984) Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest 74: 2296–2299
Larsson LI (1979) Innervation of the pancreas by substance P, enkephalin, vasoactive intestinal polypeptide and gastrin-CCK immunoreactive nerves. J Histochem Cytochem 27:1283–1284
Bishop AE, Polak JM, Green IC, Bryant MG, Bloom SR (1980) The location of VIP in the pancreas of man and rat. Diabetologia 18:73–78
Rehfeld JF, Larsson LI, Goltermann NR, Schwartz TW, Holst JJ, Jensen SL, Morley JS (1980) Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK. Nature 284:33–38
Verspohl EJ, Ammon HPT, Williams JA, Goldfine ID (1986) Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Diabetes 35: 38–43
Moghimzadeh E, Ekman R, Hákanson R, Yanaihara N, Sundler F (1983) Neuronal gastrin-releasing peptide in the mammalian gut and pancreas. Neuroscience 10: 553–563
Dunning BE, Ahrén B, Veith RC, Böttcher G, Sundler F, Taborsky Jr GJ (1986) Galanin: A novel pancreatic neuropeptide. Am J Physiol 251: E127-E133
Pettersson M, Ahrén B, Böttcher G, Sundler F (1986) Calcitonin gene-related peptide: Occurrence in pancreatic islets in the mouse and the rat and inhibition of insulin secretion in the mouse. Endocrinology 119: 865–869
Holst JJ, Fahrenkrug J, Knuhtsen S, Jensen SL, Poulsen SS, Nielsen OV (1984) Vasoactive intestinal polypeptide (VIP) in the pig pancreas: Role of VIPergic fibers in control of fluid and bicarbonate secretion. Regul Pept 8: 245–249
Knuhtsen S, Holst JJ, Jensen SL, Nielsen OV (1985) Gastrin releasing peptide: Effect on exocrine secretion and release from isolated perfused pig pancreas. Am J Physiol 248: G281-G287
Bloom SR, Edwards AV (1983) Endocrine responses to exogenous bombesin and gastrin releasing peptide in conscious calves. J Physiol 344: 37–48
Szecówka J, Lins PE, Tatemoto K, Efendić S (1983) Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats. Endocrinology 112: 1469–1473
Hermansen K (1980) Effects of substance P and other peptides on the release of somatostatin, insulin and glucagon in vitro. Endocrinology 107: 256–261
Ahrén B, Hedner P, Lundquist I (1986) Effects of six cholecystokinin (CCK) fragments on insulin secretion in the mouse. Acta Pharmacol Toxicol 58:115–120
Hermansen K (1984) Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8 and sulfated CCK-8 on pancreatic somatostatin, insulin and glucagon secretion in the dog: Studies in vitro. Endocrinology 114:1770–1775
Beglinger C, Taylor IL, Grossman MI, Solomon TE (1984) Pancreatic polypeptide release: Role of stimulants of exocrine pancreatic secretion in dogs. Gastroenterology 87: 530–536
McDonald TJ, Ghatei MA, Bloom SR, Adrian TE, Mochizaki T, Yanaihara C, Yanaihara N (1983) Dose-response comparisons of canine plasma gastroenteropancreatic hormone responses to bombesin and the porcine gastrinreleasing peptide (GRP). Regul Pept 5:125–137
Moltz JH, McDonald JK (1985) Neuropeptide Y: Direct and indirect action on insulin secretion in the rat. Peptides 6:1155–1159
Green IC, Ray K, Pervin D (1983) Opioid peptide effects on insulin release and CAMP in islets of Langerhans. Horm Metab Res 15:124–128
Ahrén B, Lundquist I (1984) Effects of naloxone on basal and stimulated insulin secretion in the mouse. Eur J Pharmacol 102: 135–139
Lundberg JM, Anggård A, Fahrenkrug J, Hökfelt T, Mutt V (1980) Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilatation and secretion. Proc Natl Acad Sci USA 77: 1651–1655
Lundberg JM, Stjärne L (1984) Neuropeptide Y (NPY) depresses the secretion of3H-noradrenaline and the contractile response evoked by field stimulation in rat vas deferens. Acta Physiol Scand 120:477–479
Gerich J, Cryer P, Rizza R (1980) Hormonal mechanisms in acute glucose counterregulation: The relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. Metabolism 29 (Suppl 1): 1164–1175
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ahrén, B., Taborsky, G.J. & Porte, D. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia 29, 827–836 (1986). https://doi.org/10.1007/BF00870137
Issue Date:
DOI: https://doi.org/10.1007/BF00870137